Similares a Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy

20 vecinos (text_768) · 55 views · HCPLive · Estados Unidos


★	Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy	HCPLive @hcplivenews	55	Estados Unidos
15	Rethinking GLP-1s: A Smarter Policy for Long-Term Metabolic Health	Metabolic Mind @metabolicmind	—	Estados Unidos	86
7	GLP-1s and Cardiovascular Risk: What the Latest Evidence Reveals	Metabolic Mind @metabolicmind	49.3K	Estados Unidos	87
18	Diabetes Dialogue: Omnipod and AID Advancements at Insulet, With Trang Ly, PhD, MBBS	HCPLive @hcplivenews	4.3K	Estados Unidos	86
19	Retatrutide Provides Substantial Weight Loss in Patients With Obesity or Overweight	HCPLive @hcplivenews	1.1K	Estados Unidos	85
9	Diabetes Dialogue: Retatrutide Phase 3 Data Show Major Weight Loss	HCPLive @hcplivenews	533	Estados Unidos	86
10	Berobenatide Monthly GLP-1 Injectable Shows Promise for Weight Loss	HCPLive @hcplivenews	250	Estados Unidos	86
16	Diabetes Dialogue: CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA	HCPLive @hcplivenews	179	Estados Unidos	86
6	Rapid Evolution in GLP-1s and Therapeutics at ADA 2026	HCPLive @hcplivenews	171	Estados Unidos	87
12	Diabetes Dialogue: CONNECT, TRANSCEND, and TRIUMPH at ADA 2026	HCPLive @hcplivenews	114	Estados Unidos	86
8	Incretins, Monitors, and Insulin Titration at ADA 2026	HCPLive @hcplivenews	76	Estados Unidos	87
11	Secret Shopper Study Reveals GLP-1 Telehealth Gaps	HCPLive @hcplivenews	70	Estados Unidos	86
4	Synergy Between Metreleptin and GLP-1 Receptor Agonists in Lipodystrophy Real-World Data Suggest	HCPLive @hcplivenews	68	Estados Unidos	89
2	METRE-PL Data Shows Severe Metabolic Disease Burden in FPLD Despite Standard Therapy	HCPLive @hcplivenews	57	Estados Unidos	90
13	#62: GLP-1s: Life-Changing Results… at What Cost?	Live Long and Well With Dr. Bobby @drbobbylivelongandwell	56	Estados Unidos	86
14	Diabetes Dialogue: Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients	HCPLive @hcplivenews	53	Estados Unidos	86
3	When to Add GLP-1 Receptor Agonists to Metreleptin in Lipodystrophy, With Lindsay Fourman, MD	HCPLive @hcplivenews	44	Estados Unidos	89
1	Metreleptin-Neutralizing Antibodies Do Not Impact Treatment Outcomes in Generalized Lipodystrophy	HCPLive @hcplivenews	40	Estados Unidos	95
17	Ersodetug Shows Target Engagement but Misses Primary Endpoints in Phase 3 cHI Study	HCPLive @hcplivenews	20	Estados Unidos	86
20	GLP-1 use in ALZHEIMER'S. What's the DATA say? #glp1 #alzheimer #insulin	Data Driven Doug @datadrivendoug	19	Estados Unidos	85
5	Structuring Obesity Trials to Optimize Patient Retention and Data Integrity	HCPLive @hcplivenews	18	Estados Unidos	88